RATIONALE: Hypereosinophilia (HE) is a persistent absolute eosinophil count (AEC) > 1500 cells/uL. The World Allergy Organization (WAO) recommends several diagnostic tests for HE patients. We analyzed utilization of WAO recommendations among patients from a large innercity population. METHODS: A retrospective chart review was conducted on HE patients from 2013-2016. Several laboratory, histopathological tests and ICD-9 diagnoses were recorded. RESULTS: 290 patients with HE were identified with a mean AEC of 2300 cells/uL (6159). Most patients were male (56%) of Hispanic origin (50%), with a mean age of 62 years (618.3). Only 23 patients (8%) had total serum IgE tested (mean level 1292 IU/ml618.3, range 6.5-5822 IU/ ml). Cortisol level was checked in 39 patients ( 13.4%) (mean level 17 mg/ dL 613.7) and tryptase in 10 patients (3.4%) (mean level 5.4 ng/mL 62.7, range 2.0-11.0 ng/mL). Strongyloides, toxocara and trichinella serologies were measured in 111 patients (39%) and 39/111 patients (35.1%) tested positive for S. stercoralis ( the remaining parasites tests were negative). Stool test for ova and parasites was checked in 35 patients (12.1%) and bone marrow biopsy was performed in 12 patients (4.2% Phoenix Children's Hospital Department of Allergy and Immunology, Phoenix, AZ. RATIONALE: Eosinophilic esophagitis is characterized by eosinophilia in conjunction with IL-33 expression. IL-33 is a proinflammatory cytokine that induces eosinophils and other cells to produce type 2 cytokines, such as IL-13. IL-33 is produced in an inactive form and stored in the cell nucleus presenting hurdles for transgenic studies of IL-33 activity. We hypothesized that transgenic expression of a secreted/active form of IL-33 would overcome these hurdles and promote eosinophilic inflammation. METHODS: We generated a secreted/active mouse IL-33 fusion gene by combining the IL-2 secretory signal peptide gene sequence with that encoding an active IL-33 fragment (a.a. 109-266). Fusion gene function was examined in vitro with a tetracycline-inducible system transfected into HEK-293 cells, and by culturing eosinophils with the HEK-293 cell culture supernatants and assessing IL-13 production by ELISA. IL-33 activity was examined in vivo by transgenic expression from the esophageal epithelium using an Epstein-Barr virus promoter (ED-L2). Mice were subjected to OVA sensitization/gastric challenge. Eosinophil densities were compared based on eosinophil peroxidase immunohistochemistry. RESULTS: Fusion gene transfected HEK-293 cells secreted an active form of IL-33 that induced eosinophils to produce IL-13. Expression of IL-33 by the esophageal epithelium resulted in increased esophageal eosinophilia relative to wild type in an OVA sensitization/challenge eosinophilic esophagitis model. CONCLUSIONS: Fusion of the IL-2 secretory signal peptide sequence with that encoding an active IL-33 fragment generated secreted/active IL-33. The ability to express secreted/active IL-33 in a cell/tissue-specific manner will facilitate studies examining IL-33 activities and mechanisms of diseases.
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Identification of reactive oxygen production site in Siglec-8 induced eosinophil death Toshihiro Tomii, MD 1 , and Gen Kano, MD PhD 2 ; 1 Kyoto Prefectural University of Medicine, Kyoto, Japan, 2 Kyoto Yamashiro General Medical Center, Kizugawa-shi, Japan; Kyoto Prefecture University of Medicine, Kyoto, Japan. RATIONALE: Siglec-8 is expressed on the surface of eosinophils and induces cell death. This function is paradoxically enhanced by costimulation with IL-5, an activation/survival factor for eosinophils. We previously reported that this cell death was dependent on intracellular reactive oxygen species (ROS) unlike ETosis, which require extracellular ROS. Here we conducted functional analysis of NAPDH oxidase (NOX) and mitochondria to identify the source of intracellular ROS production in Siglec-8 induced cell death. METHODS: Human peripheral blood eosinophils were purified and stimulated by anti-Siglec-8 monoclonal antibodies (as ligand) simultaneously with IL-5, or by Ca was not changed by Siglec-8, contrary to the significant increase by A23187. In mitochondrial analysis, mild depolarization but no ROS production was detected in Siglec-8 stimulated cells. CONCLUSIONS: NOX was turned out to be the predominant source of intracellular ROS in Siglec-8 mediated cell death. The difference in surface expression of gp91 phox may explain the difference in ROS production by Siglec-8 and ETosis stimuli, proposing previously unrecognized property of eosinophil NOX.
